Chronic Obstructive Pulmonary Disease
Showing NaN - NaN of 67
COPD Trial in Australia, New Zealand, United States (PT003 MDI, PT005 MDI, Placebo MDI)
Completed
- Chronic Obstructive Pulmonary Disease
- PT003 MDI
- +5 more
-
Clearwater, Florida
- +15 more
Mar 14, 2017
COPD Trial in Worldwide (Aclidinium bromide/formoterol Fixed-Dose Combination (FDC), Aclidinium bromide, Formoterol Fumarate)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)
- +3 more
-
Anniston, Alabama
- +207 more
Mar 9, 2017
COPD Trial in Canada, United States (Aclidinium Bromide 200 µg, Aclidinium Bromide 400 µg)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium Bromide 200 µg
- Aclidinium Bromide 400 µg
-
Birmingham, Alabama
- +112 more
Mar 9, 2017
COPD Trial in United States (tetomilast, )
Terminated
- Chronic Obstructive Pulmonary Disease
- tetomilast
- placebo
-
Birmingham, Alabama
- +14 more
Mar 3, 2017
COPD Trial in Australia, New Zealand, United States (GFF MDI, GP MDI, FF MDI)
Completed
- Chronic Obstructive Pulmonary Disease
- GFF MDI
- +4 more
-
Andalusia, Alabama
- +139 more
Feb 7, 2017
COPD Trial in Worldwide (Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium Bromide/Formoterol Fumarate
- +3 more
-
Anniston, Alabama
- +221 more
Feb 2, 2017
COPD Trial in Spartanburg (Inhaled Loxapine, Inhaled Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Inhaled Loxapine
- Inhaled Placebo
-
Spartanburg, South CarolinaSpartanburg Medical Research
Mar 13, 2017
COPD Trial in United States (Aclidinium 400 µg / Formoterol 12 µg, Aclidinium 400 µg / Formoterol 6 µg, Aclidinium 400 µg)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium 400 μg / Formoterol 12 μg
- +4 more
-
Glendale, Arizona
- +19 more
Jan 16, 2017
COPD Trial in Worldwide (MEDI8968 600 mg IV, 300 mg SC, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- MEDI8968 600 mg IV, 300 mg SC
- Placebo
-
Peoria, Arizona
- +59 more
Nov 30, 2016
COPD Trial in Canada, United States (Aclidinium bromide)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium bromide
-
Birmingham, Alabama
- +82 more
Nov 16, 2016
COPD Trial in Canada, United States (Aclidinium bromide, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium bromide
- Placebo
-
Birmingham, Alabama
- +111 more
Nov 16, 2016
COPD Trial in Spartanburg, Albrechtstrasse 14 (Placebo, NVA237)
Completed
- Chronic Obstructive Pulmonary Disease
- Placebo
- NVA237
-
Spartanburg, South Carolina
- +1 more
Aug 2, 2016
COPD Trial in United States (PT003, PT001, PT005)
Completed
- Chronic Obstructive Pulmonary Disease
- PT003
- +3 more
-
Glendale, Arizona
- +18 more
May 23, 2016
COPD Trial in United States (NVA237, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- NVA237
- Placebo
-
Homewood, Alabama
- +53 more
Feb 12, 2015
COPD Trial in Spartanburg (trospium chloride inhalation powder (TrIP), Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- trospium chloride inhalation powder (TrIP)
- Placebo
-
Spartanburg, South CarolinaUnited States Investigational Site
Dec 3, 2013
COPD Trial in Worldwide (QVA149, NVA237, tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- QVA149
- +3 more
-
Birmingham, Alabama
- +344 more
Oct 29, 2013
COPD Trial in United States (Arformoterol, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Arformoterol
- Placebo
-
Birmingham, Alabama
- +72 more
Sep 12, 2013
COPD Trial in United States (Inhaled PT001, Inhaled Placebo, Tiotropium Handihaler)
Completed
- Chronic Obstructive Pulmonary Disease
- Inhaled PT001
- +2 more
-
Peoria, Arizona
- +5 more
Jun 12, 2013
COPD Trial in United States (Fluticasone Propionate/Formoterol Fumarate, Formoterol Fumarate, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Fluticasone Propionate/Formoterol Fumarate
- +2 more
-
Phoenix, Arizona
- +22 more
May 17, 2013
COPD Trial in United States (fluticasone propionate/formoterol fumarate, fluticasone propionate, formoterol fumarate)
Completed
- Chronic Obstructive Pulmonary Disease
- fluticasone propionate/formoterol fumarate
- +2 more
-
San Diego, California
- +11 more
May 10, 2013
COPD Trial in Clearwater, Tampa, Spartanburg (PT005 MDI, Formoterol Fumarate 12 µg (Foradil® Aerolizer®), Formoterol Fumarate 24
Completed
- Chronic Obstructive Pulmonary Disease
- PT005 MDI
- +3 more
-
Clearwater, Florida
- +2 more
Sep 10, 2012
COPD Trial in Worldwide (AZD9668, AZD9668 Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- AZD9668
- AZD9668 Placebo
-
Fullerton, California
- +104 more
Jun 19, 2012
COPD, Bronchitis, Emphysema Trial in United States (Arformoterol Tartrate Inhalation Solution, Tiotropium, Arformoterol and
Completed
- Chronic Obstructive Pulmonary Disease
- +2 more
- Arformoterol Tartrate Inhalation Solution
- +3 more
-
Jasper, Alabama
- +27 more
May 29, 2012
COPD, Bronchitis, Emphysema Trial in United States (Arformoterol tartrate inhalation solution, Arformoterol 25 ug BID,
Completed
- Chronic Obstructive Pulmonary Disease
- +2 more
- Arformoterol tartrate inhalation solution
- +3 more
-
Birmingham, Alabama
- +59 more
May 29, 2012
COPD Trial in Worldwide (NVA237, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- NVA237
- Placebo
-
Spartanburg, South Carolina
- +9 more
Apr 10, 2012